Skeletal consequences of heart failure
- PMID: 36321835
- PMCID: PMC9634191
- DOI: 10.1177/17455057221135501
Skeletal consequences of heart failure
Abstract
Heart failure (HF) is a prevalent clinical syndrome that causes significant physical limitations. Osteoporosis is also an important cause of loss of functionality, and it mainly affects women. There are several reports linking HF and osteoporosis, and both share risk factors. Most of the data available so far point to bone fragility as a consequence of HF, and several mechanisms have been identified to explain this relationship. Among the proposed pathophysiological mechanisms are the hyperactivation of the renin-angiotensin-aldosterone system and the increase in parathyroid hormone, functional limitation, production of inflammatory mediators and the use of drugs for HF. The role of osteoprotegerin has gained attention owing to its cardiovascular and skeletal effects, its observed deficiency during the postmenopausal period along with its compensatory increases in HF and severe osteoporosis. The objective of this review was to perform a literature search for the main evidence on skeletal impairment in HF, with emphasis on women. As for epidemiological studies, we selected data from 3 meta-analyses and 20 individual observational studies, which together showed the interrelationship between the two clinical conditions in terms of both decreased bone density and increased fracture risk. In conclusion, HF and osteoporosis are interrelated conditions mediated by complex pathophysiological mechanisms which may be more relevant for postmenopausal women, considered to be a vulnerable population for both cardiovascular diseases and bone fragility.
Keywords: bone; bone diseases; fractures; heart; heart failure; metabolic; osteoporosis.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Epidemiology, etiology, and diagnosis of osteoporosis.Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11. doi: 10.1016/j.ajog.2005.08.047. Am J Obstet Gynecol. 2006. PMID: 16448873 Review.
-
Osteodensitometry in healthy postmenopausal women.Prescrire Int. 2008 Apr;17(94):68-72. Prescrire Int. 2008. PMID: 18536138
-
(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.Arthritis Res Ther. 2011 Jan 17;13(1):R5. doi: 10.1186/ar3224. Arthritis Res Ther. 2011. PMID: 21241491 Free PMC article. Review.
-
Heart failure as a risk factor for osteoporosis and fractures.Curr Osteoporos Rep. 2012 Dec;10(4):258-69. doi: 10.1007/s11914-012-0115-2. Curr Osteoporos Rep. 2012. PMID: 22915207 Review.
-
Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Postgrad Med. 2010. PMID: 20107292 Review.
Cited by
-
Vitamin D Deficiency in Patients Hospitalized for Heart Failure Living in the Tropics.Int J Heart Fail. 2023 Nov 14;6(2):84-90. doi: 10.36628/ijhf.2023.0025. eCollection 2024 Apr. Int J Heart Fail. 2023. PMID: 38694929 Free PMC article.
-
Bone quality, mineral density, and fractures in heart failure.PLoS One. 2023 Nov 3;18(11):e0293903. doi: 10.1371/journal.pone.0293903. eCollection 2023. PLoS One. 2023. PMID: 37922295 Free PMC article.
References
-
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021; 42(36): 3599–3726. - PubMed
-
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145(18): e895–e1032. - PubMed
-
- James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1789–1858. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous